-
Doxorubicin-based chemotherapy has remained a standard for the treatment of soft tissue sarcoma for decades. Recently, combination gemcitabine and docetaxel demonstrated significant clinical activity in a single-institution mixed population study of women with uterine leiomyosarcoma.
-
This publication is a reanalysis of 45 epidemiological studies to determine the impact of ever-use of oral contraceptives on the long-term prevention of ovarian cancer.
-
Alternatives to surgical management of vulvar intraepithelial neoplasia (VIN) are needed given the high recurrence risk and need for frequent excisional procedures.
-
n This Issue: Shingles vaccine added to CDC list of vaccines for adults 60 and older; CDC recommends Tdap for postpartum women; new study suggests sequential therapy with antibiotics for H. pylori may be more effective than standard therapy; FDA Actions.
-
Fibroids seem to strike fear in the hearts of both pregnant patients and their providers when they are foundoften for the first time during an ultrasound examination in early pregnancy.
-
The national organization in the United States dedicated specifically to the care of women with gynecological malignancy is the Society of Gynecologic Oncologists.
-
-
The SWAN is a multisite, multi ethnic, prospective, observational, longitudinal study of 3302 women who were enrolled between 1995-1997.
-
HABITS was a randomized but not placebo-controlled trial in which hormone therapy was compared to management without hormones in women with menopausal symptoms who had been previously treated for Stage I or Stage II breast cancer.1 Concomitant tamoxifen treatment was allowed in the HABITS patients but not aromatase inhibiters.
-
The authors set out to determine the preventive services and counseling provided by gynecologists, general medical physicians, or both. Using the 2000 National Health Interview Survey, the study population included women aged 18-64 years of age (with regard to Pap smear, use of tobacco, and exercise/diet counseling) and women in the 50-64 age group (previous parameters plus breast examinations, mammograms, and colon cancer screening). Sixty-two percent of patients were seen by gynecologists, 15% by general medical physicians, and 23% by both.
